Dennis M Walling

Dennis M Walling, MD, MMCI, FIDSA, currently serves as Vice President of Clinical Development and Head of Clinical Research at Seres Therapeutics, focusing on microbiome therapeutics. Prior experience includes roles as Senior Medical Director in Clinical Development at BioCryst Pharmaceuticals, Inc., and Senior Medical Director at Chimerix, Inc., where responsibilities encompassed medical, safety, and scientific oversight of clinical programs. Earlier roles included Medical Safety Director at IQVIA, Principal Consultant at Caduceus Biomedical Consulting, Associate Professor with Tenure at The University of Texas Medical Branch, and Attending Member of the Medical Staff at UNC Health Care. Walling's academic credentials include a Doctor of Medicine from The Johns Hopkins University and a Master of Management in Clinical Informatics from Duke University.